STOCK TITAN

DILLARD'S (DDS) SEC Filings, Jun-Jul 2025

DDS OTC
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Dillard’s, Inc. (DDS) – Form 4 insider filing

On 24 June 2025, Chairman & CEO William T. Dillard II reported a bona-fide gift (SEC code G) of 5,000 Class A common shares. The transaction carried a stated price of $0, confirming no sale proceeds were received.

Following the transaction, Mr. Dillard’s ownership is as follows:

  • Direct: 896,892 Class A shares
  • Retirement plan: 82 Class A shares
  • Indirect: 41,496 shares via W.D. Company, Inc.(1) and 7,300 shares as trustee of the GST Trust(2)

The gifted amount reduced his direct holdings by roughly 0.6 % (5,000 ÷ 901,892 prior shares). No derivatives or option activity was reported, and the filing contains the customary disclaimer that the insider disclaims beneficial ownership of indirectly held shares except for his pecuniary interest.

No cash sales, purchases, or new derivative grants were disclosed; therefore, the filing does not materially alter the company’s capital structure or insider ownership profile.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Form 4 filing – Dillard's, Inc. (DDS)

Director James I. Freeman reported a bona fide gift (Code G) of 250 Class A common shares on 06/24/2025 at a price of $0. After the disposition, his direct beneficial ownership totals 75,646 shares. No derivative security activity or Rule 10b5-1 plan was disclosed.

The small size of the transfer relative to Freeman’s holdings and Dillard’s overall float indicates minimal financial or signaling impact for investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many DILLARD'S (DDS) SEC filings are available on StockTitan?

StockTitan tracks 286 SEC filings for DILLARD'S (DDS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for DILLARD'S (DDS)?

The most recent SEC filing for DILLARD'S (DDS) was filed on July 2, 2025.